nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A transcranial magnetic stimulation study of the effects of olanzapine and risperidone on motor cortical excitability in patients with schizophrenia
|
Fitzgerald, Paul B. |
|
2002 |
162 |
1 |
p. 74-81 |
artikel |
2 |
Clinical applications of pharmacogenetics in psychiatry
|
Staddon, Susan |
|
2002 |
162 |
1 |
p. 18-23 |
artikel |
3 |
Clozapine is more efficacious for tongue dystonia than olanzapine
|
Conus, Philippe |
|
2002 |
162 |
1 |
p. 89 |
artikel |
4 |
Comparing the efficacy of atypical antipsychotics in open uncontrolled versus double-blind controlled trials in schizophrenia
|
Pajonk, Frank-Gerald |
|
2002 |
162 |
1 |
p. 29-36 |
artikel |
5 |
Comparison of prolactin concentrations between haloperidol and risperidone treatments in the same female patients with schizophrenia
|
Yasui-Furukori, Norio |
|
2002 |
162 |
1 |
p. 63-66 |
artikel |
6 |
Feasibility of placebo-controlled clinical trials of antipsychotic compounds in Europe
|
Fleischhacker, Wolfgang W. |
|
2002 |
162 |
1 |
p. 82-84 |
artikel |
7 |
Life is not so easy....
|
Gerlach, Jes |
|
2002 |
162 |
1 |
p. 1-2 |
artikel |
8 |
Low striatal and extra-striatal D2 receptor occupancy during treatment with the atypical antipsychotic sertindole
|
Nyberg, Svante |
|
2002 |
162 |
1 |
p. 37-41 |
artikel |
9 |
Maintenance therapy with zuclopenthixol decanoate: associations between plasma concentrations, neurological side effects and CYP2D6 genotype
|
Jaanson, Peeter |
|
2002 |
162 |
1 |
p. 67-73 |
artikel |
10 |
New study designs for new antipsychotics
|
Kahn, R. S. |
|
2002 |
162 |
1 |
p. 92 |
artikel |
11 |
Olanzapine-induced galactorrhea
|
Licht, Rasmus W. |
|
2002 |
162 |
1 |
p. 94-95 |
artikel |
12 |
Olanzapine-induced obsessive-compulsive symptoms in a patient with bipolar II disorder
|
Jonkers, Frits |
|
2002 |
162 |
1 |
p. 87-88 |
artikel |
13 |
Prolactin secretion is not a core dimension of “atypicality”
|
Gründer, Gerhard |
|
2002 |
162 |
1 |
p. 93 |
artikel |
14 |
Psychometric properties of the Subjective Well-Being Under Neuroleptics scale and the Subjective Deficit Syndrome Scale
|
de Haan, L. |
|
2002 |
162 |
1 |
p. 24-28 |
artikel |
15 |
Risperidone may induce mania
|
Güzelcan, Y. |
|
2002 |
162 |
1 |
p. 85-86 |
artikel |
16 |
Ritanserin antagonism of m-chlorophenylpiperazine effects in neuroleptic-free schizophrenics patients: support for serotonin-2 receptor modulation of schizophrenia symptoms
|
Abi-Saab, Walid |
|
2002 |
162 |
1 |
p. 55-62 |
artikel |
17 |
Second generation antipsychotics
|
Fleischhacker, W. Wolfgang |
|
2002 |
162 |
1 |
p. 90-91 |
artikel |
18 |
Significant pharmacokinetic interaction between risperidone and carbamazepine: its relationship with CYP2D6 genotypes
|
Ono, Shingo |
|
2002 |
162 |
1 |
p. 50-54 |
artikel |
19 |
Striatal dopamine-2 receptor occupancy as measured with [123I]iodobenzamide and SPECT predicted the occurrence of EPS in patients treated with atypical antipsychotics and haloperidol
|
Tauscher, Johannes |
|
2002 |
162 |
1 |
p. 42-49 |
artikel |
20 |
Subjective well-being and quality of life under atypical antipsychotic treatment
|
Karow, A. |
|
2002 |
162 |
1 |
p. 3-10 |
artikel |
21 |
The effects of second-generation antipsychotics on cognitive functioning and psychosocial outcome in schizophrenia
|
Weiss, Elisabeth M. |
|
2002 |
162 |
1 |
p. 11-17 |
artikel |